Martin MT, Patel S, Kulik L, Chan C, et al. Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings. J Hepatol 2021 Feb 27. pii: S0168-8278(21)00158.
PMID: 33652031